
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Class I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy
Kristy R. Stengel, Scott W. Hiebert
Antioxidants and Redox Signaling (2014) Vol. 23, Iss. 1, pp. 51-65
Open Access | Times Cited: 52
Kristy R. Stengel, Scott W. Hiebert
Antioxidants and Redox Signaling (2014) Vol. 23, Iss. 1, pp. 51-65
Open Access | Times Cited: 52
Showing 26-50 of 52 citing articles:
Synergistic therapeutics: Co-targeting histone deacetylases and ribonucleotide reductase for enhanced cancer treatment
Manasa Gangadhar Shetty, Padmini Pai, Mythili Padavu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116324-116324
Open Access | Times Cited: 2
Manasa Gangadhar Shetty, Padmini Pai, Mythili Padavu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116324-116324
Open Access | Times Cited: 2
Association between histone deacetylases and the loss of cochlear hair cells: Role of the former in noise-induced hearing loss
Liting Wen, Jie Wang, Ye Wang, et al.
International Journal of Molecular Medicine (2015) Vol. 36, Iss. 2, pp. 534-540
Open Access | Times Cited: 19
Liting Wen, Jie Wang, Ye Wang, et al.
International Journal of Molecular Medicine (2015) Vol. 36, Iss. 2, pp. 534-540
Open Access | Times Cited: 19
PIWIL2 suppresses Siah2-mediated degradation of HDAC3 and facilitates CK2α-mediated HDAC3 phosphorylation
Yingying Zhang, Xulei Zheng, Hao Tan, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 4
Open Access | Times Cited: 17
Yingying Zhang, Xulei Zheng, Hao Tan, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 4
Open Access | Times Cited: 17
Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia
Meng-Ping Xi, Shanshan Guo, Caicike Bayin, et al.
Frontiers of Medicine (2021) Vol. 16, Iss. 3, pp. 442-458
Open Access | Times Cited: 14
Meng-Ping Xi, Shanshan Guo, Caicike Bayin, et al.
Frontiers of Medicine (2021) Vol. 16, Iss. 3, pp. 442-458
Open Access | Times Cited: 14
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
Hong Li, Liying Ma, Xing Bian, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Hong Li, Liying Ma, Xing Bian, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 13
High-yield production of FK228 and new derivatives in a Burkholderia chassis
Kai Gong, Maoqin Wang, Qiong Duan, et al.
Metabolic Engineering (2022) Vol. 75, pp. 131-142
Open Access | Times Cited: 9
Kai Gong, Maoqin Wang, Qiong Duan, et al.
Metabolic Engineering (2022) Vol. 75, pp. 131-142
Open Access | Times Cited: 9
A comparative study on the metal complexes of an anticancer estradiol-hydroxamate conjugate and salicylhydroxamic acid
János P. Mészáros, Hilda Kovács, Gabriella Spengler, et al.
Journal of Inorganic Biochemistry (2023) Vol. 244, pp. 112223-112223
Closed Access | Times Cited: 5
János P. Mészáros, Hilda Kovács, Gabriella Spengler, et al.
Journal of Inorganic Biochemistry (2023) Vol. 244, pp. 112223-112223
Closed Access | Times Cited: 5
Image-based drug screen identifies HDAC inhibitors as novel Golgi disruptors synergizing with JQ1
Mathieu Gendarme, Jan Baumann, Tatiana I. Ignashkova, et al.
Molecular Biology of the Cell (2017) Vol. 28, Iss. 26, pp. 3756-3772
Open Access | Times Cited: 15
Mathieu Gendarme, Jan Baumann, Tatiana I. Ignashkova, et al.
Molecular Biology of the Cell (2017) Vol. 28, Iss. 26, pp. 3756-3772
Open Access | Times Cited: 15
Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma
Maša Zrimšek, Hana Kuchaříková, Kristina Draganić, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2380-2380
Open Access | Times Cited: 8
Maša Zrimšek, Hana Kuchaříková, Kristina Draganić, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2380-2380
Open Access | Times Cited: 8
Probiotics as a Therapeutic Approach in Colorectal Cancer
Nafiseh Rahmani, Ghazaleh Pourali, Nayyerehalsadat Hosseini, et al.
Current Cancer Drug Targets (2023) Vol. 23, Iss. 10, pp. 764-777
Closed Access | Times Cited: 4
Nafiseh Rahmani, Ghazaleh Pourali, Nayyerehalsadat Hosseini, et al.
Current Cancer Drug Targets (2023) Vol. 23, Iss. 10, pp. 764-777
Closed Access | Times Cited: 4
Reversion from basal histone H4 hypoacetylation at the replication fork increases DNA damage in FANCA deficient cells
Benilde García‐de Teresa, Cecilia Ayala-Zambrano, Mirna González-Suárez, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0298032-e0298032
Open Access | Times Cited: 1
Benilde García‐de Teresa, Cecilia Ayala-Zambrano, Mirna González-Suárez, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0298032-e0298032
Open Access | Times Cited: 1
Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitors
Daiqing Liao
Drug Discovery Today Technologies (2015) Vol. 18, pp. 24-28
Open Access | Times Cited: 10
Daiqing Liao
Drug Discovery Today Technologies (2015) Vol. 18, pp. 24-28
Open Access | Times Cited: 10
Design, synthesis and biological evaluation of 4-piperazinyl-containing Chidamide derivatives as HDACs inhibitors
Qingwei Zhang, Bingliu Lu, Jian-Qi Li
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 14, pp. 3162-3166
Closed Access | Times Cited: 9
Qingwei Zhang, Bingliu Lu, Jian-Qi Li
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 14, pp. 3162-3166
Closed Access | Times Cited: 9
BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination
Christopher Parker, A Chambers, Dustin J. Flanagan, et al.
DNA repair (2022) Vol. 115, pp. 103331-103331
Open Access | Times Cited: 5
Christopher Parker, A Chambers, Dustin J. Flanagan, et al.
DNA repair (2022) Vol. 115, pp. 103331-103331
Open Access | Times Cited: 5
Differential histone deacetylase inhibitor‐induced perturbations of the global proteome landscape in the setting of high‐grade serous ovarian cancer
Jolene M. Duda, Carly A. I. Twigg, Stefani N. Thomas
PROTEOMICS (2022) Vol. 23, Iss. 3-4
Open Access | Times Cited: 5
Jolene M. Duda, Carly A. I. Twigg, Stefani N. Thomas
PROTEOMICS (2022) Vol. 23, Iss. 3-4
Open Access | Times Cited: 5
Adiponectin Deficiency Suppresses Rhabdomyosarcoma Associated with Gut Microbiota Regulation
Jiao Peng, Jiayue Wang, Haifeng Huang, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 6
Jiao Peng, Jiayue Wang, Haifeng Huang, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 6
Discovery of Indole-Containing Benzamide Derivatives as HDAC1 Inhibitors with In Vitro and In Vivo Antitumor Activities
Xiu Gu, Xinyan Peng, Hao Zhang, et al.
Pharmaceutical Fronts (2022) Vol. 04, Iss. 02, pp. e61-e70
Open Access | Times Cited: 4
Xiu Gu, Xinyan Peng, Hao Zhang, et al.
Pharmaceutical Fronts (2022) Vol. 04, Iss. 02, pp. e61-e70
Open Access | Times Cited: 4
Structure-based identification of novel histone deacetylase 4 (HDAC4) inhibitors
Rupesh Agarwal, Pawat Pattarawat, Michael R. Duff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Rupesh Agarwal, Pawat Pattarawat, Michael R. Duff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Epigenetic Treatment Options in Urothelial Carcinoma
Maria Pinkerneil, Michèle J. Hoffmann, Günter Niegisch
Methods in molecular biology (2017), pp. 289-317
Closed Access | Times Cited: 3
Maria Pinkerneil, Michèle J. Hoffmann, Günter Niegisch
Methods in molecular biology (2017), pp. 289-317
Closed Access | Times Cited: 3
Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors
Rupesh Agarwal, Pawat Pattarawat, Michael R. Duff, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 867-867
Open Access
Rupesh Agarwal, Pawat Pattarawat, Michael R. Duff, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 867-867
Open Access
Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models
Ting-Yu Chang, Yan Yan, Zih-Yao Yu, et al.
Journal of Clinical Investigation (2024)
Open Access
Ting-Yu Chang, Yan Yan, Zih-Yao Yu, et al.
Journal of Clinical Investigation (2024)
Open Access
A direct alkylation route to branched derivatives of suberoylanilide hydroxamic acid (SAHA), a potent non-selective inhibitor of histone deacetylases
J. Dines, Charles M. Marson
Tetrahedron (2016) Vol. 72, Iss. 52, pp. 8584-8592
Open Access | Times Cited: 1
J. Dines, Charles M. Marson
Tetrahedron (2016) Vol. 72, Iss. 52, pp. 8584-8592
Open Access | Times Cited: 1
Role of Histone Modifications in Chronic Pain Development
Jixiang Zhang, Hui‐Lin Pan
Elsevier eBooks (2018), pp. 85-98
Closed Access
Jixiang Zhang, Hui‐Lin Pan
Elsevier eBooks (2018), pp. 85-98
Closed Access
Features of the molecular expression of alkaline phosphatase gene in chronic myeloid leukemia
L. P. Shvachko, I. V. Kravchuk, G. D. Teleheiev
Faktori eksperimental noi evolucii organizmiv (1970) Vol. 21, pp. 350-353
Open Access
L. P. Shvachko, I. V. Kravchuk, G. D. Teleheiev
Faktori eksperimental noi evolucii organizmiv (1970) Vol. 21, pp. 350-353
Open Access
Loss of BCL-3 sensitises colorectal cancer cells to DNA damage, revealing a role for BCL-3 in double strand break repair by homologous recombination
Christopher Parker, A Chambers, Dustin J. Flanagan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Christopher Parker, A Chambers, Dustin J. Flanagan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access